Security key
890260854
Tonix Pharmaceuticals Holding Corp - Common Stock (TNXP)
CUSIP: 890260854
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 13,393
- Total 13F value
- $2,493
- Share change
- -540,938
- SEC-reported price per share
- $1.00
- Number of holders
- 5
- Value change
- -$220,889
- Number of buys
- 3
- Number of sells
- 10
- Shares outstanding
- 186,616,143
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
5
Top holders
5
TNXP full security history
Ownership snapshot
Full 13F holder table
Tonix Pharmaceuticals Holding Corp. SEC filings
Tonix Pharmaceuticals Holding Corp. company facts
Broader feeds
Ownership snapshot
Top reported holders of TNXP - Tonix Pharmaceuticals Holding Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 2%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
2%
SABBY MANAGEMENT, LLC
1.7%
Alyeska Investment Group, L.P.
1.4%
MARSHALL WACE, LLP
1.3%
Rosalind Advisors, Inc.
0.48%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
2%
|
$1,519,310
3,770,000 shares
|
— | 31 Dec 2023 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
1.7%
|
$1,247,543
3,095,641 shares
|
— | 31 Dec 2023 |
| Alyeska Investment Group, L.P. |
13F
Company
|
1.4%
|
$1,089,189
2,702,702 shares
|
— | 31 Dec 2023 |
| MARSHALL WACE, LLP |
13F
Company
|
1.3%
|
$960,000
2,400,000 shares
|
— | 31 Dec 2023 |
| Rosalind Advisors, Inc. |
13F
Company
|
0.48%
|
$363,063
900,900 shares
|
— | 31 Dec 2023 |
| Altium Capital Management LLC |
13F
Company
|
0.29%
|
$217,630
540,025 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
13,393
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
5
Q1 2024 holders
5
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|